SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-154374
Filing Date
2024-06-04
Accepted
2024-06-04 17:12:58
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d820108d424b5.htm 424B5 559164
2 EX-FILING FEES d820108dexfilingfees.htm EX-FILING FEES 30159
3 GRAPHIC g811721g11a11.jpg GRAPHIC 13415
4 GRAPHIC g820108g01a01.jpg GRAPHIC 15138
5 GRAPHIC g820108g45a45.jpg GRAPHIC 47487
  Complete submission text file 0001193125-24-154374.txt   696089
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279905 | Film No.: 241019316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 212-883-0200
Royalty Pharma Holdings Ltd. (Filer) CIK: 0001868134 (see all company filings)

IRS No.: 981526515 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279905-01 | Film No.: 241019317